Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg dosages. These tablets are set to be a generic equivalent of Livalo Tablets by Kowa Company Limited, […]
Zydus Lifesciences said that it has bagged final approval for Pitavastatin Tablets, 1mg, 2mg, and 4mg from the US Food and Drug Administration (FDA). Pitavastatin Tablets is the generic version of Livalo Tablets, which is a HMG-CoA reductase inhibitor. It has approval as an adjunctive therapy to diet in adults having primary hyperlipidemia or mixed […]
